Tilray Inc (NASDAQ:TLRY – Get Free Report) was down 1.2% on Monday . The stock traded as low as $1.70 and last traded at $1.70. Approximately 7,325,389 shares were traded during trading, a decline of 71% from the average daily volume of 24,960,863 shares. The stock had previously closed at $1.72.
Tilray Trading Down 0.9 %
The company has a quick ratio of 1.42, a current ratio of 2.27 and a debt-to-equity ratio of 0.10. The stock has a fifty day simple moving average of $1.81 and a 200 day simple moving average of $1.88. The firm has a market capitalization of $1.32 billion, a P/E ratio of -3.86 and a beta of 2.13.
Tilray (NASDAQ:TLRY – Get Free Report) last issued its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million for the quarter, compared to analyst estimates of $226.20 million. During the same period in the previous year, the company posted ($0.15) earnings per share. The business’s revenue for the quarter was up 24.8% on a year-over-year basis. As a group, research analysts forecast that Tilray Inc will post -0.16 EPS for the current year.
Hedge Funds Weigh In On Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Recommended Stories
- Five stocks we like better than Tilray
- Want to Profit on the Downtrend? Downtrends, Explained.
- The Average 401k Balance by Age Explained
- Business Services Stocks Investing
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.